Annual report pursuant to Section 13 and 15(d)

Long-Term Debt and Other Financings (Tables)

v3.3.1.900
Long-Term Debt and Other Financings (Tables)
12 Months Ended
Dec. 31, 2015
Debt Disclosure [Abstract]  
Aggregate future principal and final fee payments of interest bearing obligations

Aggregate future principal, final fee payments and discounts of the Company’s total interest bearing obligations as of December 31, 2015 are as follows (in thousands):

 

Year Ended December 31,

 

Amounts

 

2016

 

$

9,038

 

2017

 

 

14,677

 

2018

 

 

17,879

 

2019

 

 

 

2020

 

 

15,664

 

 

 

 

57,258

 

Less: Interest, final payment fee, discount and issuance cost

 

 

(8,591

)

 

 

 

48,667

 

Less: interest bearing obligations – current

 

 

(5,910

)

Interest bearing obligations – non-current

 

$

42,757

 

 

Interest expense and amortization of debt issuance costs

Amortization of debt issuance costs and discounts are included in interest expense. Interest expense in the consolidated statements of comprehensive loss for the years ended December 31, 2015, 2014, and 2013 relates to the following debt instruments (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Hercules loan

 

$

2,223

 

 

$

 

 

$

 

Servier loan

 

 

1,083

 

 

 

2,330

 

 

 

2,152

 

GECC term loan

 

 

548

 

 

 

1,638

 

 

 

2,064

 

Novartis note

 

 

329

 

 

 

312

 

 

 

362

 

Other

 

 

11

 

 

 

23

 

 

 

53

 

Total interest expense

 

$

4,194

 

 

$

4,303

 

 

$

4,631